Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-24T23:28:41.233Z Has data issue: false hasContentIssue false

26 - Management of cancer of the body of the uterus

Published online by Cambridge University Press:  05 November 2015

By
Catherine Pembroke ,
Emma Hudson  and
Louise Hanna
Edited by
Louise Hanna ,
Tom Crosby  and
Fergus Macbeth
Catherine Pembroke
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff, UK
Emma Hudson
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff, UK
Louise Hanna
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff, UK
Louise Hanna
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Tom Crosby
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Fergus Macbeth
Affiliation:
Velindre Cancer Centre, Velindre Hospital, Cardiff
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Practical Clinical Oncology , pp. 360 - 373
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aalders, J., Abeler, V., Kolstad, P., et al. (1980). Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathological study of 540 patients. Obstet. Gynecol., 56, 419–427.Google Scholar
Abeler, V. M. and Kjorstad, K. E. (1991). Endometrial adenocarcinoma in Norway. A study of a total population. Cancer, 67, 3093–3103.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Akram, T., Maseelall, P. and Fanning, J. (2005). Carboplatin and paclitaxel for the treatment of advanced or recurrent endometrial cancer. Am. J. Obstet. Gynecol., 192, 1365–1367.CrossRefGoogle ScholarPubMed
Amant, F., Cadron, I., Fuso, L., et al. (2005a). Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol. Oncol., 98, 274–280.CrossRefGoogle ScholarPubMed
Amant, F., Moerman, P., Neven, P., et al. (2005b). Endometrial cancer. Lancet, 366, 491–505.CrossRefGoogle ScholarPubMed
Ambros, R. A., Sherman, M. E., Zahn, C. M., et al. (1995). Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumours displaying serous differentiation. Hum. Pathol., 26, 1260–1267.CrossRefGoogle ScholarPubMed
Andreyev, H. J., Benton, B., Lalji, A., et al. (2013). Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial. Lancet, 382, 2084–2092.CrossRefGoogle ScholarPubMed
Benedet, J. L., Bender, H., Jones, H. 3rd, et al. (2000). FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. Int. J. Gynecol. Obstet., 70, 209–262.Google ScholarPubMed
Blake, P., Swart, A., Orton, J., et al. (2009). Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review,and meta-analysis.Lancet; 373, 137–146.Google ScholarPubMed
Board of the Faculty of Clinical Oncology, The Royal College of Radiologists. (2006). Radiotherapy Dose-Fractionation. London: Royal College of Radiologists, p. 36.
Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol., 15, 10–17.CrossRefGoogle ScholarPubMed
Colombo, N., Preti, E., Landoni, F., et al. (2013). Endometrial cancer: ESMO clinical practice guidelines. Ann. Oncol., 24, vi33–vi38.CrossRefGoogle ScholarPubMed
Creutzberg, C. L., van Putten, W. L., Koper, P. C., et al. (2000). Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. Lancet, 355, 1404–1411.CrossRefGoogle ScholarPubMed
Creutzberg, C. L., van Putten, W. L., Koper, P. C., et al. (2003). Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol. Oncol., 89, 201–209.CrossRefGoogle ScholarPubMed
Creutzberg, C. L., Nout, R. A., Lybeert, M. L., et al. (2011). Fifteen year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 81, e631–638.CrossRefGoogle ScholarPubMed
Dhar, K. K., NeedhiRajan, T., Koslowski, M., et al. (2005). Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol. Oncol., 97, 924–927.CrossRefGoogle ScholarPubMed
Eifel, P., Hendrickson, M., Ross, J., et al. (1982). Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer, 50, 163–170.3.0.CO;2-K>CrossRefGoogle ScholarPubMed
ESTRO. (2002). The GEC ESTRO Handbook of Brachytherapy, ed. Gerbaulet, A., Potter, R., Mazeron, J.-J., et al. Brussels: ESTRO, Chapter 15, pp. 365–401.
FIGO. (2009). FIGO staging for uterine sarcomas. Int. J. Gynecol. Obstet., 104, 179.CrossRef
Fiorica, J. V., Brunetto, V. L., Hanjani, P., et al. (2004). Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol, Oncol., 92, 10–14.CrossRefGoogle ScholarPubMed
Galaal, K., Bryant, A., Fisher, A., et al. (2012). Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2012 Sep 12;9:CD006655.CrossRefGoogle ScholarPubMed
Gredmark, T., Kvint, S., Havel, G., et al. (1995). Histopathological findings in women with postmenopausal bleeding. Br. J. Obstet. Gynaecol., 102, 133–136.CrossRefGoogle ScholarPubMed
Gupta, J. K., Chien, P. F., Voit, D., et al. (2002). Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet. Gynecol. Scand., 81, 799–816.CrossRefGoogle ScholarPubMed
Hensley, M. L., Maki, R., Venkatraman, E., et al. (2002). Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J. Clin. Oncol., 20, 2824–2831.CrossRefGoogle ScholarPubMed
Hogberg, T. (2008). Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials. Clin. Oncol. (R. Coll. Radiol.), 20, 463–469.CrossRefGoogle ScholarPubMed
Jones, D. A. and Stout, R. (1986). Results of intracavitary radium treatment for adenocarcinoma of the body of the uterus. Clin. Radiol., 37, 169–171.CrossRefGoogle ScholarPubMed
Johnson, N., Bryant, M., Miles, T., et al. (2011). Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst. Rev. doi: 10.1002/14651858.CD003175.pub2CrossRefGoogle ScholarPubMed
Kanjeekal, S., Chambers, A., Fung, M. F., et al. (2005). Systemic therapy for advanced uterine sarcomas: a systematic review of the literature. Gynecol. Oncol., 97, 624–637.CrossRefGoogle ScholarPubMed
Keys, H. M., Roberts, J. A., Brunetto, V. L., et al. (2004). A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol., 92, 744–751.CrossRefGoogle ScholarPubMed
Kieser, K. and Oza, A. M. (2005). What's new in systemic therapy for endometrial cancer. Curr. Opin. Oncol., 17, 500–504.CrossRefGoogle ScholarPubMed
Kim, S. H., Kim, H. D., Song, Y. S., et al. (1995). Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT and MRI.J. Comput. Assist. Tomogr., 19, 766–772.CrossRefGoogle ScholarPubMed
Kitchener, H., Blake, P., Sanderock, J., Parmer, M., ASTEC Study Group. (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study, Lancet; 373, 125–136.Google ScholarPubMed
Kokka, F., Brockbank, E., Oram, D., et al. (2010). Hormonal therapy in advanced or recurrent endometrial cancer. Cochrane Database Syst. Rev., 12, CD007926.Google Scholar
Kong, A., Johnson, N., Kitchener, H. C., et al. (2012). Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J. Natl Cancer Inst., 104, 1625–1634.CrossRefGoogle Scholar
Kurman, R. J., Kaminski, P. F. and Norris, H. J. (1985). The behaviour of endometrial hyperplasia. A long-term study of ‘untreated’ hyperplasia in 170 patients. Cancer, 56, 403–412.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Lai, C. H. and Huang, H. J. (2006). The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer. Curr. Opin. Obstet. Gynecol., 18, 29–34.Google ScholarPubMed
Lewin, S., Herzog, T., Medel, N., et al. (2010). Comparative performance of the 2009 International Federation of Gynecology and Obstetrics’ staging system for uterine corpus cancer. Obstet. Gynecol., 116, 1141–1149.CrossRefGoogle ScholarPubMed
Livi, L., Andreopoulou, E., Shah, N., et al. (2004). Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1988. Clin. Oncol. (R. Coll. Radiol.), 16, 261–268.CrossRefGoogle Scholar
Maggi, R., Lissoni, A., Spina, M., et al. (2006). Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br. J. Cancer, 95, 266–271.CrossRefGoogle ScholarPubMed
Martin-Hirsch, P. L., Lilford, R. J. and Jarvis, G. J. (1996). Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analysis of published randomised controlled trials. Eur. J. Obstet. Gynecol. Reprod. Biol., 65, 201–207.CrossRefGoogle ScholarPubMed
Michener, C. M., Peterson, G., Kulp, B., et al. (2005). Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma. J. Cancer Res. Clin. Oncol., 131, 581–584.CrossRefGoogle ScholarPubMed
Montz, F. J., Bristow, R. E., Bovicelli, A., et al. (2002). Intrauterine progesterone treatment of early endometrial cancer. Am. J. Obstet. Gynecol., 186, 651–657.CrossRefGoogle ScholarPubMed
Nag, S., Erickson, B., Parikh, S., et al. (2000). The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int. J. Radiat. Oncol. Biol. Phys., 48, 779–790.Google ScholarPubMed
NICE. (2007). Heavy Menstrual Bleeding NICE Clinical Guideline 44.London: National Institute for Health and Care Excellence.
NICE. (2015). Suspected cancer: recognition and referral. NICE guideline. London: National Institute for Health and Care Excellence.
Niwa, K., Tagami, K., Lian, Z., et al. (2005). Outcome of fertility-preserving treatment in young women with endometrial carcinomas. Br. J. Obstet. Gynecol., 112, 317–320.CrossRefGoogle ScholarPubMed
Nordal, R. N., Kjørstad, K. E., Stenwigh, A. E., et al. (1993). Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985. Int. J. Gynecol. Cancer, 3, 110–115.CrossRefGoogle ScholarPubMed
Nout, R. A., Smit, V. T., Putter, H., et al. (2010). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet, 375, 816–823.CrossRefGoogle ScholarPubMed
Oza, A. M., Elit, L. and Tsao, M. (2011). Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC clinical trials group. J.Clin. Oncol., 29, 3278–3285.CrossRefGoogle ScholarPubMed
Park., J. Y., Kim, D. Y., Kim, T. J., et al. (2013a). Hormonal therapy for women with stage IA endometrial cancer of all grades. Obstet. Gynecol., 122, 7–14.CrossRefGoogle ScholarPubMed
Park, H., Nam, E., Sunghoon, K., et al. (2013b). The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 170, 39–44.CrossRefGoogle ScholarPubMed
Pecorelli, S., et al., FIGO Committee on Gynecologic Oncology. (2009). Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynecol. Obstet., 105, 103–104.Google Scholar
Reed, N. S. (2008). The management of uterine sarcomas. Clin. Oncol. (R Coll Radiol.), 20, 470–478.CrossRefGoogle ScholarPubMed
Reed, N.S., Mangioni, C., Malmström, H., et al. (2008). Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur. J. Cancer, 44, 808–818.Google Scholar
Schouten, L. J., Goldbohm, R. A. and van den Brandt, P. A. (2004). Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J. Natl Cancer Inst., 96, 1635–1638.CrossRefGoogle ScholarPubMed
Small, W., Mell, L., Anderson, P., et al. (2008). Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial and cervical cancer. Int. J. Radiat. Oncol. Biol. Phys., 71, 428–434.CrossRefGoogle ScholarPubMed
Tsoref, D. and Oza, A. (2011). Recent advances in systemic therapy for advanced endometrial cancer. Curr. Opin. Oncol., 23, 494–500.CrossRefGoogle ScholarPubMed
Whitney, C. W., Brunetto, M. F., Homesley, H. D., et al. (2004). Phase II study of medroxy-progesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol., 92, 4–9.CrossRefGoogle Scholar
WHO classification. (2003). In World Health Organization Classification of Tumours: Pathology and genetics of tumours of the breast and female genital organs, ed. Tavassoli, A. and Devilee, P.. Lyon: IARC Press, Chapter 4.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×